These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1539986)

  • 1. Novel assay for screening rifamycin B-producing mutants.
    Vohra RM
    Appl Environ Microbiol; 1992 Jan; 58(1):403-4. PubMed ID: 1539986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New rifamycins produced by a recombinant strain of Nocardia mediterranei.
    Schupp T; Traxler P; Auden JA
    J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain.
    Ghisalba O; Fuhrer H; Richter WJ; Moss S
    J Antibiot (Tokyo); 1981 Jan; 34(1):58-63. PubMed ID: 7251510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei.
    White RJ; Martinelli E; Lancini G
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Sartori G
    J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-factor, an essential regulatory substance inducing the production of rifamycin in a Nocardia sp.
    Kawaguchi T; Asahi T; Satoh T; Uozumi T; Beppu T
    J Antibiot (Tokyo); 1984 Dec; 37(12):1587-95. PubMed ID: 6526727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. V. Studies on the biogenetic origin of 3-substituents.
    Traxler P; Ghisalba O
    J Antibiot (Tokyo); 1982 Oct; 35(10):1361-6. PubMed ID: 7174520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains].
    Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE
    Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit.
    Ghisalba O; Nüesch J
    J Antibiot (Tokyo); 1981 Jan; 34(1):64-71. PubMed ID: 7251511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp.
    Kawaguchi T; Azuma M; Horinouchi S; Beppu T
    J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis.
    Ghisalba O; Roos R; Schupp T; Nüesch J
    J Antibiot (Tokyo); 1982 Jan; 35(1):74-80. PubMed ID: 7200089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea.
    Martinelli E; Antonini P; Cricchio R; Lancini G; White RJ
    J Antibiot (Tokyo); 1978 Oct; 31(10):949-51. PubMed ID: 711618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei.
    Lee KJ; Rho YT
    J Biotechnol; 1994 Aug; 36(3):239-45. PubMed ID: 7765266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 16,17-dihdrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S. Two novel rifamycins from a recombinant strain C 5/42 of Nocardia mediterranei.
    Traxler P; Schupp T; Wehrli W
    J Antibiot (Tokyo); 1982 May; 35(5):594-601. PubMed ID: 7107523
    [No Abstract]   [Full Text] [Related]  

  • 17. Overproduction of rifamycin B by Amycolatopsis mediterranei and its relationship with the toxic effect of barbital on growth.
    Mejía A; Barrios-González J; Viniegra-González G
    J Antibiot (Tokyo); 1998 Jan; 51(1):58-63. PubMed ID: 9531988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electron microscopic study of active and inactive variants of Proactinomyces (Nocardia) mediterranei, a producer of rifamycin B].
    Zaslavskaia PL; Teteriatnik AF; Zhukov VG; Dzegilenko NB
    Antibiotiki; 1978 Mar; 23(3):208-11. PubMed ID: 637526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea.
    Cricchio R; Antonini P; Ferrari P; Ripamonti A; Tuan G; Martinelli E
    J Antibiot (Tokyo); 1981 Oct; 34(10):1257-60. PubMed ID: 7309622
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifamycin SV and related ansamycins.
    Chiao JS; Xia TH; Mei BG; Jin ZK; Gu WL
    Biotechnology; 1995; 28():477-98. PubMed ID: 8688635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.